Patent · US Active

Immobilised biological entities

US11850334B2 · kind B2 · utility

0Cited by

3References

32Claims

0Family size

Assignee

CARMEDA AB · SE

Inventors

Dagmar Pikas · Upplands Väsby, SE
Johan Riesenfeld · Upplands Väsby, SE
Karin Leontein · Upplands Väsby, SE
Eva KOCH
Stefan Oscarson · Stockholm, SE

Key dates

Filing date	Oct 3, 2019
Grant date	Dec 26, 2023
Priority date	—
Expiry date	Apr 22, 2040

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61L2300/42
WIPO fieldMedical technology
WIPO sectorInstruments

Abstract

There is provided inter alia an anticoagulant surface which surface has covalently bound thereto a plurality of fragments of heparin, wherein said fragments consist of 5-18 saccharide units and at least some of said plurality of fragments comprise polysaccharide sequence A, which surface catalyses the inhibition of FIIa and FXa by AT.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.